Back to company

EPITHERAPEUTICS ApS: Financial statements 2020

CVR: 30523067

EPITHERAPEUTICS ApS (CVR 30523067) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -398,217 and a net result of DKK -3,028,693 compared with DKK 600,267 the year before. Equity amounted to DKK 30,279,232. The solvency ratio was 98.8%.

Gross Profit
-398,217 kr.
Profit/Loss
-3,028,693 kr.
Equity
30,279,232 kr.
Total Assets
30,642,458 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--398 t.-3 mio.30.3 mio.-
2019--198 t.600 t.33.3 mio.-
2018--135 t.1.6 mio.32.7 mio.-
2017--636 t.-35.7 mio.32 mio.-
2016-448 mio.356.4 mio.396.1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is EPITHERAPEUTICS ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

EPITHERAPEUTICS ApS: The 2019 annual report is outApr 2, 2020

EPITHERAPEUTICS ApS has published its annual report for 2019. Gross profit came to DKK -198,198, and the net result was DKK 600,267.

About EPITHERAPEUTICS ApS

EPITHERAPEUTICS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2008 and dissolved in 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee. In 2021, the company reported a gross profit of DKK 72,058 and a net result of DKK -21,073,661 compared with DKK -3,028,693 the year before. Equity amounted to DKK 9,205,571.